Physician profile
Cori Devon Kellner
NPI 1376968032
$6,193.86
in general payments reported to CMS, 2019-2025
33 companies · $1,307 in 2025
The $1,307 reported for 2025 was more than what 98% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $982 · 2022: $1,170 · 2023: $1,366 · 2024: $1,369 · 2025: $1,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,041.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $1,076.04 | 2021-2025 | |
| Abbvie INC. | $844.45 | 2021-2025 | |
| Exeltis, USA INC. | $775.38 | 2021-2025 | Slynd, Nuvessa, Nuvessa |
| Astellas Pharma US INC | $588.83 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $339.65 | 2024-2025 | Myfembree |
| Hologic Sales and Service, LLC | $335.41 | 2021-2025 | Fluent Fluid Management System, Aptima, Thinprep 2000 Processor |
| Millicent US INC | $334.70 | 2022-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $232.42 | 2021-2024 | |
| Organon LLC | $187.48 | 2021-2025 | Nexplanon |
| Currax Pharmaceuticals LLC | $176.83 | 2021-2023 | Contrave, Onzetra Xsail |
| Idorsia Pharmaceuticals US INC | $171.64 | 2022-2024 | Quviviq |
| Evofem Biosciences, INC. | $124.71 | 2021-2022 | |
| Momentis Surgical INC. | $105.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.31 | 2021-2025 | |
| Therapeuticsmd, INC. | $77.85 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $77.40 | 2021-2022 | |
| Novo Nordisk INC | $76.90 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Avion Pharmaceuticals | $74.03 | 2021-2023 | Balcoltra |
| Biohaven Pharmaceutical Holding Company Ltd. | $60.38 | 2022 | |
| Lilly USA, LLC | $58.42 | 2023-2025 | Zepbound, Emgality, Reyvow |
| Shield Therapeutics INC | $55.89 | 2023-2025 | Accrufer |
| Myovant Sciences INC. | $44.17 | 2021 | |
| Exact Sciences Corporation | $43.72 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $43.31 | 2024 | Interstim |
| Lupin INC. | $34.49 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.55 | 2023 | Trintellix |
| Coopersurgical, INC. | $23.78 | 2023 | Paragard T 380a |
| Vertex Pharmaceuticals Incorporated | $20.39 | 2025 | |
| Daiichi Sankyo INC. | $19.93 | 2024 | Injectafer |
| Ascend Therapeutics US, LLC | $19.53 | 2024 | |
| Merck Sharp & Dohme LLC | $18.16 | 2021 | |
| Roche Diagnostics Corporation | $14.84 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cori Kellner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.